×
Back to Agenda
Driving Enrollment with a Patient-Centric Focus to Artificial Intelligence
Session Chair(s)
Rob Wynden, PHD
Chief Executive Officer, Aloha Health Network, United States
Artificial intelligence, blockchain, natural language processing and real world evidence have been all the rage lately in industry news. Hear perspectives on these new technologies from a panel of experts from sponsor, technology vendor, patient advocacy group, and patients on what's working and what's not.
Learning Objective : Describe how to drive patient enrollment in clinical studies with a patient-centric approach, allowing patients to pre-screen themselves and retargeting them if excluded; Identify how to address patient recruitment issues associated with pre-screening, screening and dropout to reduce the current average conversion ratio from 10:1; Discuss how to reduce pre-screening burden via mining of EMR records.
Speaker(s)
Introduction to Patient-Facing Trial Technology
Chief Executive Officer, Aloha Health Network, United States
A Bulls-Eye Clinical Trial via Patient's Point- of-View
Chief Medical Advisor, Medical Advisory Board, WeHeal Foundation, United States
User-Driven Markets Data that Help Clinicians Assess Treatments and Cure Diseases
Founder, Chief Executive Officer, The Health Exchange Market (THEM), United States
Turning Clinical Trial Recruitment on its Head Using EHR-Connected Applicants
Director of Product, Sharecare, United States
Pragmatism and AI in Research
Chief Executive Officer, Signant Health, United States
Have an account?